{"group": "KXWEIGHTDRUGSQ", "count": 5, "markets": [{"ticker": "KXWEIGHTDRUGSQ-1-25-7", "event_ticker": "KXWEIGHTDRUGSQ-1-25", "market_type": "binary", "title": "Will weight loss drug prescriptions grow by above 7%?", "subtitle": "7%", "yes_sub_title": "7% or above", "no_sub_title": "7% or above", "open_time": "2025-01-15T15:00:00Z", "close_time": "2025-04-25T18:00:25.62916Z", "expected_expiration_time": "2025-05-11T14:00:00Z", "expiration_time": "2025-06-10T14:00:00Z", "latest_expiration_time": "2025-06-10T14:00:00Z", "settlement_timer_seconds": 3600, "status": "finalized", "response_price_units": "usd_cent", "notional_value": 100, "notional_value_dollars": [0, 0], "yes_bid": 5, "yes_bid_dollars": [0, 0], "yes_ask": 11, "yes_ask_dollars": [0, 0], "no_bid": 89, "no_bid_dollars": [0, 0], "no_ask": 95, "no_ask_dollars": [0, 0], "last_price": 10, "last_price_dollars": [0, 0], "previous_yes_bid": 5, "previous_yes_bid_dollars": [0, 0], "previous_yes_ask": 11, "previous_yes_ask_dollars": [0, 0], "previous_price": 10, "previous_price_dollars": [0, 0], "volume": 14825, "volume_24h": 0, "liquidity": -19178, "liquidity_dollars": [0, 0], "open_interest": 9291, "result": "no", "settlement_value": 0, "can_close_early": true, "expiration_value": "3.2%", "category": "", "risk_limit_cents": 0, "yes_topbook_liquidity_dollars": [0, 0], "no_topbook_liquidity_dollars": [0, 0], "strike_type": "greater", "floor_strike": 7, "rules_primary": "If prescriptions made for weight loss drugs (using semaglutide and tirzepatide) grow by 7% in Q1 2025, then the market resolves to Yes.", "rules_secondary": "The number of weight drug prescriptions at the end of Q3 was 3,540,489.", "tick_size": 1}, {"ticker": "KXWEIGHTDRUGSQ-1-25-5", "event_ticker": "KXWEIGHTDRUGSQ-1-25", "market_type": "binary", "title": "Will weight loss drug prescriptions grow by above 5%?", "subtitle": "5%", "yes_sub_title": "5% or above", "no_sub_title": "5% or above", "open_time": "2025-01-15T15:00:00Z", "close_time": "2025-04-25T18:00:28.855991Z", "expected_expiration_time": "2025-05-11T14:00:00Z", "expiration_time": "2025-06-10T14:00:00Z", "latest_expiration_time": "2025-06-10T14:00:00Z", "settlement_timer_seconds": 3600, "status": "finalized", "response_price_units": "usd_cent", "notional_value": 100, "notional_value_dollars": [0, 0], "yes_bid": 16, "yes_bid_dollars": [0, 0], "yes_ask": 23, "yes_ask_dollars": [0, 0], "no_bid": 77, "no_bid_dollars": [0, 0], "no_ask": 84, "no_ask_dollars": [0, 0], "last_price": 24, "last_price_dollars": [0, 0], "previous_yes_bid": 16, "previous_yes_bid_dollars": [0, 0], "previous_yes_ask": 23, "previous_yes_ask_dollars": [0, 0], "previous_price": 24, "previous_price_dollars": [0, 0], "volume": 9532, "volume_24h": 0, "liquidity": -28979, "liquidity_dollars": [0, 0], "open_interest": 7619, "result": "no", "settlement_value": 0, "can_close_early": true, "expiration_value": "3.2%", "category": "", "risk_limit_cents": 0, "yes_topbook_liquidity_dollars": [0, 0], "no_topbook_liquidity_dollars": [0, 0], "strike_type": "greater", "floor_strike": 5, "rules_primary": "If prescriptions made for weight loss drugs (using semaglutide and tirzepatide) grow by 5% in Q1 2025, then the market resolves to Yes.", "rules_secondary": "The number of weight drug prescriptions at the end of Q3 was 3,540,489.", "tick_size": 1}, {"ticker": "KXWEIGHTDRUGSQ-1-25-15", "event_ticker": "KXWEIGHTDRUGSQ-1-25", "market_type": "binary", "title": "Will weight loss drug prescriptions grow by above 15%?", "subtitle": "15%", "yes_sub_title": "15% or above", "no_sub_title": "15% or above", "open_time": "2025-01-15T15:00:00Z", "close_time": "2025-04-25T18:00:22.460281Z", "expected_expiration_time": "2025-05-11T14:00:00Z", "expiration_time": "2025-06-10T14:00:00Z", "latest_expiration_time": "2025-06-10T14:00:00Z", "settlement_timer_seconds": 3600, "status": "finalized", "response_price_units": "usd_cent", "notional_value": 100, "notional_value_dollars": [0, 0], "yes_bid": 1, "yes_bid_dollars": [0, 0], "yes_ask": 3, "yes_ask_dollars": [0, 0], "no_bid": 97, "no_bid_dollars": [0, 0], "no_ask": 99, "no_ask_dollars": [0, 0], "last_price": 2, "last_price_dollars": [0, 0], "previous_yes_bid": 1, "previous_yes_bid_dollars": [0, 0], "previous_yes_ask": 3, "previous_yes_ask_dollars": [0, 0], "previous_price": 2, "previous_price_dollars": [0, 0], "volume": 8668, "volume_24h": 0, "liquidity": 0, "liquidity_dollars": [0, 0], "open_interest": 3283, "result": "no", "settlement_value": 0, "can_close_early": true, "expiration_value": "3.2%", "category": "", "risk_limit_cents": 0, "yes_topbook_liquidity_dollars": [0, 0], "no_topbook_liquidity_dollars": [0, 0], "strike_type": "greater", "floor_strike": 15, "rules_primary": "If prescriptions made for weight loss drugs (using semaglutide and tirzepatide) grow by 15% in Q1 2025, then the market resolves to Yes.", "rules_secondary": "The number of weight drug prescriptions at the end of Q3 was 3,540,489.", "tick_size": 1}, {"ticker": "KXWEIGHTDRUGSQ-1-25-12", "event_ticker": "KXWEIGHTDRUGSQ-1-25", "market_type": "binary", "title": "Will weight loss drug prescriptions grow by above 12%?", "subtitle": "12%", "yes_sub_title": "12% or above", "no_sub_title": "12% or above", "open_time": "2025-01-15T15:00:00Z", "close_time": "2025-04-25T18:00:19.189159Z", "expected_expiration_time": "2025-05-11T14:00:00Z", "expiration_time": "2025-06-10T14:00:00Z", "latest_expiration_time": "2025-06-10T14:00:00Z", "settlement_timer_seconds": 3600, "status": "finalized", "response_price_units": "usd_cent", "notional_value": 100, "notional_value_dollars": [0, 0], "yes_bid": 2, "yes_bid_dollars": [0, 0], "yes_ask": 4, "yes_ask_dollars": [0, 0], "no_bid": 96, "no_bid_dollars": [0, 0], "no_ask": 98, "no_ask_dollars": [0, 0], "last_price": 2, "last_price_dollars": [0, 0], "previous_yes_bid": 2, "previous_yes_bid_dollars": [0, 0], "previous_yes_ask": 4, "previous_yes_ask_dollars": [0, 0], "previous_price": 2, "previous_price_dollars": [0, 0], "volume": 11345, "volume_24h": 0, "liquidity": -476, "liquidity_dollars": [0, 0], "open_interest": 7985, "result": "no", "settlement_value": 0, "can_close_early": true, "expiration_value": "3.2%", "category": "", "risk_limit_cents": 0, "yes_topbook_liquidity_dollars": [0, 0], "no_topbook_liquidity_dollars": [0, 0], "strike_type": "greater", "floor_strike": 12, "rules_primary": "If prescriptions made for weight loss drugs (using semaglutide and tirzepatide) grow by 12% in Q1 2025, then the market resolves to Yes.", "rules_secondary": "The number of weight drug prescriptions at the end of Q3 was 3,540,489.", "tick_size": 1}, {"ticker": "KXWEIGHTDRUGSQ-1-25-10", "event_ticker": "KXWEIGHTDRUGSQ-1-25", "market_type": "binary", "title": "Will weight loss drug prescriptions grow by above 10%?", "subtitle": "10%", "yes_sub_title": "10% or above", "no_sub_title": "10% or above", "open_time": "2025-01-15T15:00:00Z", "close_time": "2025-04-25T18:00:15.447496Z", "expected_expiration_time": "2025-05-11T14:00:00Z", "expiration_time": "2025-06-10T14:00:00Z", "latest_expiration_time": "2025-06-10T14:00:00Z", "settlement_timer_seconds": 3600, "status": "finalized", "response_price_units": "usd_cent", "notional_value": 100, "notional_value_dollars": [0, 0], "yes_bid": 2, "yes_bid_dollars": [0, 0], "yes_ask": 6, "yes_ask_dollars": [0, 0], "no_bid": 94, "no_bid_dollars": [0, 0], "no_ask": 98, "no_ask_dollars": [0, 0], "last_price": 2, "last_price_dollars": [0, 0], "previous_yes_bid": 2, "previous_yes_bid_dollars": [0, 0], "previous_yes_ask": 6, "previous_yes_ask_dollars": [0, 0], "previous_price": 2, "previous_price_dollars": [0, 0], "volume": 16625, "volume_24h": 0, "liquidity": 0, "liquidity_dollars": [0, 0], "open_interest": 12049, "result": "no", "settlement_value": 0, "can_close_early": true, "expiration_value": "3.2%", "category": "", "risk_limit_cents": 0, "yes_topbook_liquidity_dollars": [0, 0], "no_topbook_liquidity_dollars": [0, 0], "strike_type": "greater", "floor_strike": 10, "rules_primary": "If prescriptions made for weight loss drugs (using semaglutide and tirzepatide) grow by 10% in Q1 2025, then the market resolves to Yes.", "rules_secondary": "The number of weight drug prescriptions at the end of Q3 was 3,540,489.", "tick_size": 1}]}